Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 7, 2011; 17(29): 3441-3447
Published online Aug 7, 2011. doi: 10.3748/wjg.v17.i29.3441
Published online Aug 7, 2011. doi: 10.3748/wjg.v17.i29.3441
Table 2 Endoscopic findings between treatment groups n (%)
| Pantoprazole group(n = 52) | Somatostatin group(n = 49) | Total cohort(n = 101) | P value | |
| Cause of bleeding | 0.177 | |||
| Gastric ulcer | 27 (51.9) | 29 (59.2) | 56 (55.4) | |
| Duodenal ulcer | 11 (21.2) | 8 (16.3) | 19 (18.8) | |
| Dieulafoy lesion | 13 (25.0) | 7 (14.3) | 20 (19.8) | |
| Mallory–Weiss syndrome | 1 (1.9) | 5 (10.2) | 6 (5.9) | |
| Forrest type | 0.894 | |||
| Ia | 3 (5.8) | 4 (8.2) | 7 (6.9) | |
| Ib | 24 (46.2) | 22 (44.9) | 46 (45.5) | |
| IIa | 25 (48.1) | 23 (46.9) | 48 (47.5) | |
| Loss of stigma | 49 (94.2) | 47 (95.9) | 96 (95.0) | 0.696 |
- Citation: Choi CW, Kang DH, Kim HW, Park SB, Park KT, Kim GH, Song GA, Cho M. Somatostatin adjunctive therapy for non-variceal upper gastrointestinal rebleeding after endoscopic therapy. World J Gastroenterol 2011; 17(29): 3441-3447
- URL: https://www.wjgnet.com/1007-9327/full/v17/i29/3441.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i29.3441